Triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray [Nasacort] — RxCUI 1797915
RxNorm drug concept · Semantic branded drug
RxCUI 1797915
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
6 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1797915
Official nameTriamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray [Nasacort]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNasacort 55 MCG/ACTUAT Metered Dose Nasal Spray; Nasacort 0.055 MG/ACTUAT Metered Dose Nasal Spray
FDA products mapped2
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Triamcinolone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes, intra-articular triamcinolone is specifically approved to give short-term relief for knee arthritis, gout flares, bursitis, and similar joint conditions. The extended-release...
- I'm getting a triamcinolone injection in my knee. Will it actually help, and how long does it last?
- That's a really important thing to flag with your doctor before your injection or prescription. Triamcinolone can raise blood sugar — even in people whose diabetes is well-controll...
- I have diabetes. Should I be worried about using triamcinolone?
🕸️ Concept Web — How Triamcinolone acetonide 0.055 MG/ACTUAT Metered... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray [Nasacort]
RxCUI 1797915 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Triamcinolone
10759IN -
Triamcinolone acetonide
10761PIN
-
Triamcinolone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Nasacort
153239BN
-
Nasacort
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Triamcinolone Metered Dose Nasal Spray
1797903SCDF -
Triamcinolone acetonide Metered Dose Nasal Spray
2646495SCDFP -
Triamcinolone Inhalant Product
1158223SCDG -
Triamcinolone Nasal Product
1158225SCDG -
Triamcinolone acetonide Inhalant Product
2660847SCDGP -
Triamcinolone acetonide Nasal Product
2659518SCDGP -
Triamcinolone Metered Dose Nasal Spray [Nasacort]
1797914SBDF -
Triamcinolone acetonide Metered Dose Nasal Spray [Nasacort]
2654650SBDFP - +5 more in this family
-
Triamcinolone Metered Dose Nasal Spray
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray
1797913SCD -
Triamcinolone acetonide 0.055 MG/ACTUAT
1085794SCDC -
Triamcinolone acetonide 0.055 MG/ACTUAT [Nasacort]
1085796SBDC
-
Triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray
SCD · 1797913 -
Triamcinolone acetonide 0.055 MG/ACTUAT
SCDC · 1085794 -
Triamcinolone Metered Dose Nasal Spray
SCDF · 1797903 -
Triamcinolone acetonide Metered Dose Nasal Spray
SCDFP · 2646495 -
Triamcinolone Inhalant Product
SCDG · 1158223 -
Triamcinolone Nasal Product
SCDG · 1158225 -
Triamcinolone acetonide Inhalant Product
SCDGP · 2660847 -
Triamcinolone acetonide Nasal Product
SCDGP · 2659518
Brand-Name Concepts
-
Triamcinolone acetonide 0.055 MG/ACTUAT [Nasacort]
SBDC · 1085796 -
Triamcinolone Metered Dose Nasal Spray [Nasacort]
SBDF · 1797914 -
Triamcinolone acetonide Metered Dose Nasal Spray [Nasacort]
SBDFP · 2654650 -
Nasacort Inhalant Product
SBDG · 1179329 -
Nasacort Nasal Product
SBDG · 1801240 -
Nasacort
BN · 153239
📦 FDA Products & Package NDCs
2 products · 6 package NDCs
6 package NDCs map to RxCUI 1797915 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 41167-5800-01 | 1 BOTTLE, SPRAY in 1 CARTON (41167-5800-1) / 30 SPRAY, METE... | Nasacort Allergy 24HR | Chattem, Inc. | 2017-09-07 |
| 41167-5800-02 | 2 BOTTLE, SPRAY in 1 CARTON (41167-5800-2) / 120 SPRAY, MET... | Nasacort Allergy 24HR | Chattem, Inc. | 2014-02-03 |
| 41167-5800-03 | 1 BOTTLE, SPRAY in 1 CARTON (41167-5800-3) / 60 SPRAY, METE... | Nasacort Allergy 24HR | Chattem, Inc. | 2014-02-03 |
| 41167-5800-05 | 1 BOTTLE, SPRAY in 1 CARTON (41167-5800-5) / 120 SPRAY, MET... | Nasacort Allergy 24HR | Chattem, Inc. | 2014-02-03 |
| 41167-5800-06 | 4 BOTTLE, SPRAY in 1 CARTON (41167-5800-6) / 120 SPRAY, MET... | Nasacort Allergy 24HR | Chattem, Inc. | 2021-07-01 |
| 50090-1444-00 | 1 BOTTLE, SPRAY in 1 CARTON (50090-1444-0) / 120 SPRAY, MET... | NASACORT | A-S Medication Solutions | 2014-11-28 |
Observed labelers:
Chattem, Inc. (5) ·
A-S Medication Solutions (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.